arrow
A

Anne Bauters

chu-lille
H指数:21
被引数:3,710

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Laboratory Monitoring of UFH in Different Settings (DEXHEP Study): Association between Anti-Xa Levels, Platelet Factor 4 (PF4) Plasma Levels and Dextran Sulfate

不同临床环境下UFH的实验室监测(DEXHEP研究):抗Xa水平、血小板因子4(PF4)血浆水平与右旋糖酐硫酸盐之间的关系

2025-12-010
OA
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology
2023-09-016
OAAI
Factors Influencing anti-Xa assays: A Multicenter Prospective Study in Critically Ill and Noncritically Ill Patients Receiving Unfractionated Heparin
2023-06-159
PRE
GFHT proposals on the practical use of argatroban - With specifics regarding vaccine-induced immune thrombotic thrombocytopaenia (VITT)
2021-12-018
PREAI
Heparin-induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation
2021-08-019
PREAI
Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19
2021-05-0582
OA
BLOC1S5pathogenic variants cause a new type of Hermansky-Pudlak syndrome

Bloc1s5致病性变异引起新型hermansky-pudlak综合征

2020-10-0154
OAAI
Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature
2020-06-2230
PREAI
Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study
2017-10-0121
PREAI
Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia

微粒表型与驱动突变和原发性血小板增多症的不同血栓形成风险相关

2016-05-3120
OAAI
Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders
2016-04-2683
OAAI